drugset

Drugs / HMW-HA

Follow last change Sep 2023 re-read 2 minutes ago

HMW-HA

also known as High Molecular Weight Hyaluronic Acid · High molecular weight hyaluronan

Other / unclassified

Developed for: chronic obstructive pulmonary disease · COVID-19
Investigated by: Campus-Bio-Medico University · National Institute of Environmental Health Sciences (NIEHS)

Trials 1 · a red edge is where a trial was stopped

today NCT02674880 · Ph 2

20162017201820192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT02674880	Mar 2016 → Jan 2019	chronic obstructive pulmonary disease	Campus-Bio-Medico University	Completed	No outcome recorded

Also used as a comparator or background therapy in 2 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 21 trial
Phase 2	NCT04830020 Comparator	Feb → Jun 2021	COVID-19	Campus-Bio-Medico University	Completed	No outcome recorded
Phase 31 trial
Phase 3	NCT06178367 Comparator	Aug → Sep 2023	—	Indonesia University	Completed	No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

Field	Value	Cited text
Known as	HMW-HA	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04830020 ↗ 1 NCT02674880 ↗
Known as	High molecular weight hyaluronan	“High molecular weight hyaluronan (HMW-HA) is a glycosaminoglycan sugar, which is a physiological constituent of the lung extracellular matrix and has notable anti-inflammatory...” PMID 33517896 ↗ Feb 2021
Known as	High Molecular Weight Hyaluronic Acid	“The objective of this study is to test the effect of High Molecular Weight Hyaluronic Acid (HMW-HA) on Non Invasive Ventilation (NIV) effectiveness in patients admitted to a...” NCT02674880 ↗ 1 NCT06178367 ↗
Modality	Other / unclassified	“High molecular weight hyaluronan (HMW-HA) is a glycosaminoglycan sugar” PMID 33517896 ↗ Feb 2021
Route	Other	“via nebulizer b.i.d.” NCT02674880 ↗